Cancers that express estrogen receptor alpha (ER+ breast cancers) constitute the most plentiful subset of these cancers, and the importance of estrogenic signals in fueling tumor behavior has led to targeted therapies that are major components of standard treatments. The gene discussed is ESR1; the disease is neoplasm.